Literature DB >> 11819254

Codon 249 mutations of p53 gene in development of hepatocellular carcinoma.

Xiao-Mou Peng, Wen-Wei Peng, Ji-Lu Yao.   

Abstract

AIM:To investigate the mechanisms of codon 249 mutation of p53 gene in the formation of hepatocellular carcinoma (HCC).
METHODS: Codon 249 mutation accompanied by loss of heterozygosity (LOH) and its effect on translation and transcription were studied using SSCP, IHC and RT-PCR/slot hybridization.
RESULTS: Codon 249 mutations were detected in 32.9%, LOH detected in 68.4% among the HCC patients.Mutations of condon 249 were accompanied by LOH in 90%.The positive rates of p53 protein and mRNA were 91.3% and 95.7%, in mutational group, both were significantly higher than those in the non-mutational group (91.3% vs 19.1% and 95.7% vs 40.4%, respectively, both P < 0.01). The translation of p53 gene was strongly related to its transcription by correlation analysis( r = 0.8208).
CONCLUSION: LOH might play an important role in hepatocarcinogenesis of codon 249 mutation, which could increase both transcription and translation of p53 gene.The increased expression of p53 protein mainly depend on the increased transcription of p53 gene.

Entities:  

Year:  1998        PMID: 11819254      PMCID: PMC4688632          DOI: 10.3748/wjg.v4.i2.125

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  10 in total

1.  [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].

Authors:  L Qin; Z Tang; K Liu
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1995-11

Review 2.  Loss of constitutional heterozygosity in human cancer.

Authors:  D Lasko; W Cavenee; M Nordenskjöld
Journal:  Annu Rev Genet       Date:  1991       Impact factor: 16.830

3.  Overexpression of p53 in hepatocellular carcinomas: a clinicopathological and prognostic correlation.

Authors:  I O Ng; E C Lai; A S Chan; M K So
Journal:  J Gastroenterol Hepatol       Date:  1995 May-Jun       Impact factor: 4.029

4.  Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma.

Authors:  Y Yumoto; T Hanafusa; H Hada; T Morita; S Ooguchi; N Shinji; T Mitani; K Hamaya; N Koide; T Tsuji
Journal:  J Gastroenterol Hepatol       Date:  1995 Mar-Apr       Impact factor: 4.029

5.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

6.  An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.

Authors:  Y Soini; S C Chia; W P Bennett; J D Groopman; J S Wang; V M DeBenedetti; H Cawley; J A Welsh; C Hansen; N V Bergasa; E A Jones; A M DiBisceglie; G E Trivers; C A Sandoval; I E Calderon; L E Munoz Espinosa; C C Harris
Journal:  Carcinogenesis       Date:  1996-05       Impact factor: 4.944

Review 7.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

8.  Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.

Authors:  Y S Shieh; C Nguyen; M V Vocal; H W Chu
Journal:  Int J Cancer       Date:  1993-06-19       Impact factor: 7.396

Review 9.  Cellular and molecular mechanisms of hepatocarcinogenesis.

Authors:  C E Rogler; F V Chisari
Journal:  Semin Liver Dis       Date:  1992-08       Impact factor: 6.115

10.  The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan.

Authors:  H Hayashi; K Sugio; T Matsumata; E Adachi; K Takenaka; K Sugimachi
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

  10 in total
  17 in total

1.  Effect of 5-Aza-2'-deoxycytidine on the P16 tumor suppressor gene in hepatocellular carcinoma cell line HepG2.

Authors:  L H Liu; W H Xiao; W W Liu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Overexpression of p27(KIP1) induced cell cycle arrest in G(1) phase and subsequent apoptosis in HCC-9204 cell line.

Authors:  Jiang Li; Xin-Ke Yang; Xin-Xin Yu; Meng-Liang Ge; Wen-Liang Wang; Jie Zhang; Yun-De Hou
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

3.  Methylation status of c-fms oncogene in HCC and its relationship with clinical pathology.

Authors:  J Cui; D H Yang; X J Bi; Z R Fan
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

4.  p73beta inhibits transcriptional activities of enhancer I and X promoter in hepatitis B virus more efficiently than p73alpha.

Authors:  Zhen-Hua Xu; Mu-Jun Zhao; Tsai-Ping Li
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Expression of nuclear factor-kappa B in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus.

Authors:  S P Guo; W L Wang; Y Q Zhai; Y L Zhao
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

6.  Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines.

Authors:  Miao-Wang Hao; Ying-Rui Liang; Yan-Fang Liu; Li Liu; Ming-Yao Wu; Huan-Xing Yang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

7.  Rapid screening mitochondrial DNA mutation by using denaturing high-performance liquid chromatography.

Authors:  Man-Ran Liu; Kai-Feng Pan; Zhen-Fu Li; Yi Wang; Da-Jun Deng; Lian Zhang; You-Yong Lu
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

8.  TECA hybrid artificial liver support system in treatment of acute liver failure.

Authors:  Y L Xue; S F Zhao; Y Luo; X J Li; Z P Duan; X P Chen; W G Li; X Q Huang; Y L Li; X Cui; D G Zhong; Z Y Zhang; Z Q Huang
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

9.  Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC.

Authors:  Chong Lu; Hui-Mian Xu; Qun Ren; Yang Ao; Zhen-Ning Wang; Xue Ao; Li Jiang; Yang Luo; Xue Zhang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

10.  Novel assay of competitively differentiated polymerase chain reaction for screening point mutation of hepatitis B virus.

Authors:  Xiao-Mou Peng; Xue-Juan Chen; Jian-Guo Li; Lin Gu; Yang-Su Huang; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.